novartis glp-1 receptor agonist Heterogeneity in response to agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study | Diabetologia Glucagon-like peptide 1 (GLP-1) -
Description
Data represents mean SEM
Three steps
[DOI] [PubMed] [Google Scholar] 620.Sun F., Wu S., Guo S., Yu K., Yang Z., Li L
Yang et al., 2020)
The differences go deeper than receptor count
Liraglutide improves treatment satisfaction in people with type 2 diabetes compared to sitagliptin, each as add-on to metformin
